Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kubota Pharmaceutical Holdings Co Buyback Yield % Chart
TSE:4596 vs VRTX, REGN, ALNY: Buyback Yield % Comparison
For the Biotechnology subindustry, Kubota Pharmaceutical Holdings Co's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kubota Pharmaceutical Holdings Co Buyback Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kubota Pharmaceutical Holdings Co's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Kubota Pharmaceutical Holdings Co's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kubota Pharmaceutical Holdings Co (TSE:4596) has a Buyback Yield % of -2.30 as of Jul. 18, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Kubota Pharmaceutical Holdings Co and its competitors. According to the industry distribution chart, Kubota Pharmaceutical Holdings Co ranks #238 out of 740 companies in the Biotechnology industry, placing it in the top 32.2%.
Is Kubota Pharmaceutical Holdings Co's Buyback Yield % too high?
Kubota Pharmaceutical Holdings Co's current Buyback Yield % is -2.30. Based on the distribution chart, Kubota Pharmaceutical Holdings Co ranks #238 out of 740 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Kubota Pharmaceutical Holdings Co has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Kubota Pharmaceutical Holdings Co's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kubota Pharmaceutical Holdings Co ranks #238 out of 740 companies for Buyback Yield %. This puts Kubota Pharmaceutical Holdings Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Kubota Pharmaceutical Holdings Co and its competitors. Kubota Pharmaceutical Holdings Co's current Buyback Yield % is -2.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kubota Pharmaceutical Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Kubota Pharmaceutical Holdings Co (TSE:4596) is currently considered Significantly Overvalued. The stock's GF Value™ is 円16.36, compared to a current price of 円65.00 — trading 297.3% above its estimated fair value. The current Buyback Yield % is -2.30. Kubota Pharmaceutical Holdings Co's overall GF Score™ is 39/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Kubota Pharmaceutical Holdings Co (TSE:4596), the current Buyback Yield % is -2.30 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kubota Pharmaceutical Holdings Co (TSE:4596) Overvalued in 2026?
Based on GuruFocus' analysis, Kubota Pharmaceutical Holdings Co stock appears to be overvalued.
The current stock price of 円65.00 is trading 297.3% above its estimated GF Value™ of 円16.36.
GuruFocus considers Kubota Pharmaceutical Holdings Co to be Significantly Overvalued.
Key valuation signals for TSE:4596:
Buyback Yield %: -2.30
GF Value™: 円16.36 vs. price of 円65.00 (297.3% above fair value)
No single metric tells the full story. See the TSE:4596 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kubota Pharmaceutical Holdings Co Business Description
Kubota Pharmaceutical Holdings Co Ltd is a Japanese company providing portfolio of drugs and devices to preserve and restore millions of people. It identifies and develops therapeutics to treat the opthalmic disorder and operations incidental or related thereto. Its pipeline products include VCM-Emixustat HCI, Lanosterol and Optogenetics.
39GF Score
Get the complete analysis for TSE:4596
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4596 has been successfully added to your 
